No black box warning on record for Zingo

As of the latest FDA labeling reviewed, Zingo (LIDOCAINE HYDROCHLORIDE MONOHYDRATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Zingo medicine page for the complete safety profile.

Other warnings & precautions

---------------WARNINGS AND PRECAUTIONS--------------- Methemoglobinemia : Cases of methemoglobinemia have been reported in association with local anesthetic use. (5.1) Use on intact skin only (2.1, 5) Avoid contact with the eye (2.1, 5) Do not use if device is dropped or the pouch is damaged or torn (2.1) Patients with bleeding tendencies or platelet disorders could have a higher risk of superfic
5 WARNINGS AND PRECAUTIONS Do not use around the eyes. Do not use ZINGO on body orifices, mucous membranes, or on areas with a compromised skin barrier. Only use ZINGO on skin locations where an adequate seal can be maintained. Patients with severe hepatic disease or pseudocholinesterase deficiency, because of their inability to metabolize local anesthetics normally, are at a greater risk of devel
5.1 Methemoglobinemia Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites

No black box warning on record for Zingo

Other warnings & precautions

---------------WARNINGS AND PRECAUTIONS--------------- Methemoglobinemia : Cases of methemoglobinemia have been reported in association with local anesthetic use. (5.1) Use on intact skin only (2.1, 5) Avoid contact with the eye (2.1, 5) Do not use if device is dropped or the pouch is damaged or torn (2.1) Patients with bleeding tendencies or platelet disorders could have a higher risk of superfic
5 WARNINGS AND PRECAUTIONS Do not use around the eyes. Do not use ZINGO on body orifices, mucous membranes, or on areas with a compromised skin barrier. Only use ZINGO on skin locations where an adequate seal can be maintained. Patients with severe hepatic disease or pseudocholinesterase deficiency, because of their inability to metabolize local anesthetics normally, are at a greater risk of devel
5.1 Methemoglobinemia Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites

Zingo Black Box Warning

No black box warning on record for Zingo

Other warnings & precautions

Zingo Black Box Warning

No black box warning on record for Zingo

Other warnings & precautions